Partner Content Partner Content 6 Ways To Finally Drug RAS Oncogenes Are You Developing Effective Anti-RAS Therapeutics?
Partner Content Partner Content Boehringer Ingelheim to present data at RAS Summit Europe RAS- Targeted Drug Discovery Europe Conference
News Hims & Hers buys Australian digital health firm for $1.15bn Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by buying Eucalyptus Health.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
